The discovery of the XMRV retrovirus in most chronic fatigue syndrome (ME/CFS) patients could be a demarcating point in the history of this illness. The publication of the study in Science, the most prestigious scientific journal in the world, by a stellar cast of researchers from the National Cancer Institute, the Cleveland Clinic and the Whittemore Peterson Institute prompted a flood of stories across the major media outlets and scientific publications including Nature, Scientific American, the New York Times, (two articles), NPR, Fox News, LA Times, etc.
Amid concerns that the blood supply was contaminated the NIH officials announced they’d already held a conference on the issue. The Whittemore Peterson Institute rapidly conferred a new name for what it believes are a cadre of XMRV diseases they’re choosing to call XAND (X Associated Neuroimmune Diseases).
Questions were quickly raised concerning prevalence, transmission, testing, treatment, etc. Much is still unknown about this new finding with news coming in almost daily.
- Clinical Director Dr. Deckoff-Jones Talks On the WPI’s Clinic
- Dr. Mikovits- the Santa Rosa Lecture
- Dr. Mikovits In Sweden: New Findings on XMRV
- Researchers on XMRV: the Twix podcast with Dr. Racaniello
- A ‘Draw’ at the Blood Working Group”
- XMRV at the Tipping Point: A Tale of Two Conferences
- Batter Up! The XMRV/MLV Debate Continues
- Pathogen Ace To Lead Major New NIH XMRV Study
Phoenix Rising has many resources on XMRV.